<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
Russell W. Jenkins(Broad Institute), Mei-Ju Su(Dana-Farber Cancer Institute), Susanna Stinson(Gilead Sciences (United States)), Adriano Piris(Brigham and Women's Hospital), Joshua A. Kaplan(Gilead Sciences (United States)), Meng Xiao He(Broad Institute), Mai P. Hoang(Harvard University), Diana Miao(Broad Institute), María Anguiano(Universidad de Navarra), Asaf Rotem(AstraZeneca (South Korea)), Glenn J. Hanna(Dana-Farber Cancer Institute), Michal Barzily-Rokni(Shaare Zedek Medical Center), Zhiheng Jia(Gilead Sciences (United States)), Alicia Smart(Brigham and Women's Hospital), Hans Vitzthum(Harvard University), Marc R. Hammond(Harvard University), William H. Walker(University of Pittsburgh), Chensheng W. Zhou(Dana-Farber Cancer Institute), Tran C. Thai(Dana-Farber Cancer Institute), Sangeetha Palakurthi, Max M. Quinn(Dana-Farber Cancer Institute), Jean-Pierre Eliane(Massachusetts General Hospital), Raven Vlahos(Dana-Farber Cancer Institute), Chandrasekar Venkataramani(Gilead Sciences (United States)), Elena V. Ivanova(Massachusetts General Hospital), Michaela Bowden(Brigham and Women's Hospital), Patrick H. Lizotte(Harvard University), Lauren Keogh(Dana-Farber Cancer Institute), Gao Zhang(Central South University), Wei Huang(Chinese Academy of Sciences), Andrew Portell(Massachusetts General Hospital), Amir Reza Aref(Massachusetts General Hospital), Prafulla C. Gokhale(Harvard University), Chaoran Cheng(Peking University), Lance Stapleton(Gilead Sciences (United States)), Eric S. Wang(Massachusetts Eye and Ear Infirmary), Lisa Cameron(University of North Carolina at Chapel Hill), Israel Cañadas(Fox Chase Cancer Center), Ashley A. Merlino(Dana-Farber Cancer Institute), Anat Stemmer‐Rachamimov(Massachusetts General Hospital), Hua Zhang(University of Hong Kong), Shuai Li(First Affiliated Hospital of Liaoning Medical University), Hongye Liu(Dana-Farber Cancer Institute), Robert E. Jones(Beth Israel Deaconess Medical Center), Jong Wook Kim(University of California San Diego), Tian Tian(Illinois Institute of Technology), Mark Bittinger(Dana-Farber Cancer Institute), Zhi Wei(New Jersey Institute of Technology), Bart Phillips(Gilead Sciences (United States)), Jiehui Deng(NYU Langone Health)
Cited by 591